OBJECTIVE -To clarify the relationship between lipid levels and ischemic heart disease (IHD) and cerebrovascular disease (CVD) in diabetic individuals.
T ype 2 diabetes, dyslipidemia, and aging are independent risk factors for cardiovascular diseases. Japanese individuals have lower rates of ischemic heart disease (IHD) and higher rates of cerebrovascular disease (CVD); however, diabetic individuals have an increased risk of IHD (1, 2) . Risk factors for IHD or CVD in elderly diabetic individuals are not fully known (3) , and the Japan Cholesterol and Diabetes Mellitus Study was formulated to evaluate them (Umin Clinical Trials Registry, clinical trial reg. no. UMIN00000516; http://www.umin. ac.jp/ctr/index.htm). .3% of patients enrolled in the first and second years, respectively. Patients were divided into those aged Ͻ65 years, 65-74 years, and Ͼ75 years (n ϭ 1,267, 1,731, and 1,016, respectively). The primary end points were onset of IHD or CVD. Plasma lipid, glucose, A1C, and other relevant levels were measured annually.
RESEARCH DESIGN AND METHODS
The study was approved by institutional review boards and by the safetymonitoring board. All events were confirmed by the organizing committee annually. The guidelines of the Japan Atherosclerosis Society (2002) , stating that LDL cholesterol should be Ͻ120 mg/dl and HDL cholesterol Ͼ40 mg/dl in diabetic individuals, and the American Diabetes Association criteria for diagnosis of type 2 diabetes were used (4, 5) .
Results are presented as means Ϯ SD. All statistical analyses were performed using JMP software (SAS Institute, Cary, NC). Incidences were analyzed in relation to risk factors. Univariate and multiple logistic regression analysis and stepwise analysis were used. Values of P Ͻ 0.05 were considered significant.
RESULTS -M e a n A 1 C , f a s t i n g plasma glucose, LDL cholesterol, triglyceride, HDL cholesterol, and systolic and diastolic blood pressure levels on registration were 7.53 Ϯ 1.12%, 159.4 Ϯ 52.7
mg/dl, 120.3 Ϯ 32 mg/dl, 140.6 Ϯ 108.3 mg/dl, 55.8 Ϯ 18.0 mg/dl, 136.5 Ϯ 17.1 mmHg, and 75.1 Ϯ 11.1 mmHg, respectively. Insulin and oral agents for diabetes were prescribed for 19.9 and 70.5% of individuals, respectively. Dyslipidemia was seen in 79.1%, and antihyperlipidemic drugs were prescribed in 59.0%. Mean lipid and glucose metabolism levels did not change significantly over the 2-year study period.
In the first and second years, 83 and 69 vascular events occurred, respectively. IHD and CVD occurred in 0.80 and 0.71% of total patients per year. The relationship between IHD or CVD and background factors such as LDL cholesterol levels in each age-group was analyzed by univariate logistic regression.
Sex, age, LDL cholesterol, HDL cholesterol, and triglyceride were significantly related to IDH in patients aged Ͻ65 years. Age, sex, history of hypertension, and antihypertensive drugs were related in patients aged between 65 and 74 years, and sex and systolic and diastolic blood pressure were related in patients aged Ͼ 75 years. CVD and LDL cholesterol were related in patients aged Ͻ65 years, and HDL cholesterol and systolic blood pressure were related in patients aged Ͼ75 years.
We performed multiple regression analysis with factors found to be significant by univariate regression analysis for IHD or CVD and other atherogenic riskrelated factors (A1C, etc.) in three agegroups (Table 1) . LDL and HDL cholesterol were associated with IHD in patients aged Ͻ 65 years but not in other agegroups. Sex was associated with IHD in individuals aged Ͻ74 years. HDL cholesterol was also associated with CVD in individuals between aged between 65 and 74 years and Ͼ75 years.
Stepwise multiple regression analysis was performed using factors that were found to be significant by univariate regression analysis for IHD or CVD and other atherogenic risk-related factors. The relation of age or HDL cholesterol to IHD and CVD was evaluated in quartile categories. HDL cholesterol levels were inversely correlated with IHD in individuals aged Ͻ65 years (hazards ratio 0.633 [95% CI 0.428 -0.975]) but not in other groups. The relationship between CVD and HDL cholesterol was prominent in those aged Ͼ75years but not in other agegroups (Table 1 ). There were no sexrelated differences in the relationship of HDL cholesterol with CVD. There was no relationship between LDL, triglyceride, fasting blood glucose, or A1C and the frequency of CVD. Data were adjusted for sex. The ratio of male to female subjects is 1:1. *Statistically significant (P Ͻ0.05). DBP, diastolic blood pressure; SBP, systolic blood pressure.
CONCLUSIONS -This study represents one of the largest-scale attempts to examine IHD and CVD in middle-aged and elderly diabetic individuals. In the U.S., evidence suggests that middle-aged diabetic individuals have an IHD risk similar to that for individuals with myocardial infarction (6) . However, this risk may not exist in elderly diabetic individuals. Many guidelines to prevent atherothrombotic diseases recommend strict control of LDL cholesterol in diabetic patients but the same guideline for HDL cholesterol control (40 mg/dl) as that used for nondiabetic subjects (4 -7). A novel finding was that type 2 diabetic elderly individuals had frequent CVD, and incidence rates were associated with HDL cholesterol. Few data were available for the relationship among elderly, type 2 diabetes, and CVD (8, 9) .
There have been three large-scale clinical studies of statins that included participants aged up to 75 years (10 -12) . Although they reported that statins exerted effects on IHD (including in diabetic individuals), effects were not pronounced. (Prosper reported that statins induced a 16% decrease in IHD without any effects on CVD.) The data suggest that because LDL cholesterol decreased, simple LDL cholesterol control may not prevent IHD or CVD in elderly individuals. Our study shows the importance of HDL cholesterol in CVD in elderly diabetic individuals and in IHD in middle-aged diabetic individuals. If HDL cholesterol is well controlled in elderly diabetic patients, then CVD and IHD might be decreased to the levels found in middle-aged cohorts. Patients prescribed statins whose HDL cholesterol was Ͻ40 mg/dl showed the same risk (data not shown). Although medicated patients may be more conscious of diseases, HDL cholesterol is a strong risk factor and masks the effects of statins.
In conclusion, HDL and LDL cholesterol were risk factors for IHD in diabetic patients aged Ͻ65 years. In addition, HDL cholesterol was a risk factor for CVD in elderly diabetic subjects, especially those aged Ͼ75 years. HDL cholesterol may help prevent CVD in elderly diabetic subjects. Risk factors for IHD and CVD appear to change with advancing age.
